Barriers to COVID-19 Vaccine Uptake in the LGBTQIA Community.
Am J Public Health
; 112(3): 405-407, 2022 03.
Article
in English
| MEDLINE | ID: covidwho-1708980
ABSTRACT
Objectives. To report findings from qualitative research that describe sources of hesitancy and barriers to vaccine uptake among lesbian, gay, bisexual, transgender, queer, intersex, and asexual (LGBTQIA) populations. Methods. In March 2021, we conducted focus groups with members of the Los Angeles, California LGBTQIA community to identify barriers to becoming vaccinated. Semistructured interviews were conducted with 32 individuals in 5 focus groups. Thematic analysis was conducted to identify themes. Results. Historical and ongoing medical trauma, including misgendering, and perceived emotional violence emerged as significant barriers to LGBTQIA individuals becoming vaccinated. Fear of violence was found to be a major barrier among transgender individuals, whereas fear of an unwelcoming vaccination site was a barrier for seniors. Finally, surviving was a higher priority than becoming vaccinated. Conclusions. Participants reported vaccine hesitancy and barriers that are unique to the life experiences of LGBTQIA individuals; these include medical trauma, violence, stigma, and discrimination. Our findings highlight the need to include LGBTQIA leaders and trusted individuals in the development of vaccination education and the delivery of vaccination services. (Am J Public Health. 2022;112(3)405-407. https//doi.org/10.2105/AJPH.2021.306599).
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Sexual and Gender Minorities
/
COVID-19 Vaccines
/
COVID-19
/
Vaccination Hesitancy
Type of study:
Experimental Studies
/
Observational study
/
Prognostic study
/
Qualitative research
/
Randomized controlled trials
Topics:
Vaccines
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
/
Young adult
Country/Region as subject:
North America
Language:
English
Journal:
Am J Public Health
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS